ADRIANNE SIMPSON: Open Payments
NPI 1255953907 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 12 payments from 7 companies in 2025. Trend: 2023 $468 · 2024 $649 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $220 |
| ABBVIE INC. | 1 | $141 |
| Novo Nordisk Inc | 2 | $92 |
| PFIZER INC. | 2 | $35 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Neos Therapeutics, LP | 1 | $19 |
Products named: VRAYLAR, BREZTRI, AIRSUPRA, Ozempic, Quviviq, ZORYVE, NURTEC ODT, Adzenys XR-ODT.
Industry payments across MO — which companies pay providers there.
